JPS6497A - 16-membered ring macrolide compound - Google Patents
16-membered ring macrolide compoundInfo
- Publication number
- JPS6497A JPS6497A JP15482687A JP15482687A JPS6497A JP S6497 A JPS6497 A JP S6497A JP 15482687 A JP15482687 A JP 15482687A JP 15482687 A JP15482687 A JP 15482687A JP S6497 A JPS6497 A JP S6497A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- coc
- membered ring
- compound shown
- macrolide compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- HDFRDWFLWVCOGP-UHFFFAOYSA-N carbonothioic O,S-acid Chemical compound OC(S)=O HDFRDWFLWVCOGP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
NEW MATERIAL:A compound shown by formula I [n is 0 or 1; R0 is H or alkyl; A is OH, =0 or group shown by formula II; R1 is OCH3 or CH3; R2 is H or CH3; R3 is H, CH3, CH2OH or group shown by formula III; R4 is CH3 of C2H5; R5 is H, COCH3 or COC2H5; R6 is H or COC2H5, COC3H7 or COCH2 CH(CH3)2] and an acid addition salt thereof.
EXAMPLE: A compound shown by formula IV.
USE: An antimicrobial agent for oral administration.
PREPARATION: A compound shown by formula V is reacted with a mercaptocarboxylic acid in an organic solvent containing no active hydrogen in the presence of 1,3-dicyclohexylcarbodiimide and optionally a base at -25W60°C for 1W6 days.
COPYRIGHT: (C)1989,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62-154826A JPH0197A (en) | 1987-06-22 | 16-membered ring macrolide compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62-154826A JPH0197A (en) | 1987-06-22 | 16-membered ring macrolide compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6497A true JPS6497A (en) | 1989-01-05 |
| JPH0197A JPH0197A (en) | 1989-01-05 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI906204A0 (en) | A process for the preparation of pharmaceutically active peptide compounds | |
| IL93050A0 (en) | Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ATE109149T1 (en) | 3-PYRROLIDINYLTHIO-1-AZABICYCLO(3.2.0>-HEPT-2-E - 2-CARBONIC ACID COMPOUNDS. | |
| GB8826595D0 (en) | Active compounds | |
| DE3850603D1 (en) | Arylaralkyl ethers, process for their preparation and pharmaceutical composition containing them. | |
| EP0281412A3 (en) | Novel organic platinum complex pharmaceutical compositions containing same and a process for the preparation thereof | |
| SE9703056L (en) | Clavulanic acid salts, process for their preparation and pharmaceutical compositions containing them | |
| JPS6497A (en) | 16-membered ring macrolide compound | |
| HUT49887A (en) | Process for producing new cefem compounds | |
| JPS56118015A (en) | Immunological activator containing organic germanium compound | |
| JPS56103185A (en) | Malonamidoxa-dethia-cephem compound | |
| JPS572298A (en) | Erythromycin derivative | |
| JPS55164672A (en) | Azetidine derivative and its preparation | |
| JPS57106644A (en) | Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation | |
| JPS57139015A (en) | Remedy for infectious disease for oral administration | |
| JPS5569569A (en) | Carcinostatic | |
| JPS643144A (en) | Novel cyclic compound and antilipemic agent containing said compound as active component | |
| BG95629A (en) | Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations | |
| JPS57171989A (en) | Aminometyl-secalonic acid and its preparation | |
| EP0306863A3 (en) | New cephem compounds and processes for preparation thereof | |
| JPS54135771A (en) | Novel antibiotic substance 4a-epinanaomycin b and its preparation | |
| JPS5387358A (en) | Gamma-pyrone compound, its preparation and agricultural medicine therefrom | |
| JPS5444696A (en) | Condensed isoxazole compound and its preparation | |
| JPS5782376A (en) | Novel antibiotic substance saphenamycin and its preparation | |
| IE812421L (en) | Peptides |